Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 4 7Phase 1 7Phase NA 6Phase 1/2 4Phase 2/3 3Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1

Conditions

Polycystic Ovary Syndrome 1Neoplasms 1Myofibroma 1Acute Kidney Injury 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Acetylcysteine × Clear all
NCT07156786 2025-09-19

N-Acetylcysteine Roles in Preserving Renal Function Measured by Urinary KIM-1 (Kidney Injury Molecule-1) and Serum Creatinine on Cancer Patients With Cisplatin Based Chemotherapy: A Randomized Placebo-Controlled Trial

Fakultas Kedokteran Universitas Indonesia

Phase 2/3 Not yet recruiting
72 enrolled
Genitourinary

Neoplasms, Acute Kidney Injury

NCT06115408 2024-12-16

Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma

Ain Shams University

Phase 2/3 Completed
40 enrolled

Myofibroma

NCT02775734 2017-05-02

NAC

Ain Shams University

Phase 2/3 Completed
144 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡